{"id":20556,"date":"2025-09-26T23:32:06","date_gmt":"2025-09-27T02:32:06","guid":{"rendered":"https:\/\/monsenhorpaulo.mg.gov.br\/site\/?p=20556"},"modified":"2026-09-26T18:32:09","modified_gmt":"2026-09-26T21:32:09","slug":"labako-kaezino-un-latvijas-nakotnes-veselibas-inovacijas","status":"publish","type":"post","link":"https:\/\/monsenhorpaulo.mg.gov.br\/site\/emdestaque\/labako-kaezino-un-latvijas-nakotnes-veselibas-inovacijas\/","title":{"rendered":"Labako Ka\u0113zino un Latvijas N\u0101kotnes Vesel\u012bbas Inov\u0101cijas"},"content":{"rendered":"<p>\nM\u016bsdienu medic\u012bnas un biotehnolo\u0123iju att\u012bst\u012bba ir atkar\u012bga no p\u0113t\u012bjumu sadarb\u012bbas inov\u0101ciju centr\u0101laj\u0101 d\u012bgtuv\u0113 un tehnolo\u0123iju laboratorij\u0101s. Viens no iz\u0161\u0137iro\u0161ajiem aspektiem ir Latvijas sp\u0113ju iesaist\u012bties glob\u0101lajos vesel\u012bbas un biotehnolo\u0123iju ekosist\u0113m\u0101s, izmantojot inov\u0101ciju platformas un ekspertu t\u012bklus. \u0160aj\u0101 kontekst\u0101 biotehnolo\u0123iju port\u0101ls un inform\u0101cijas avots, piem\u0113ram, <a href=\"https:\/\/www.lastingwinz.org\/labako-kaezino\/\">lastingwinz<\/a>, pied\u0101v\u0101 dzi\u013c\u0101ku ieskatu par Latvijas lab\u0101kajiem agrobiotehnolo\u0123iju projektiem un to noz\u012bmi vesel\u012bbas att\u012bst\u012bb\u0101.<\/p>\n<h2>Labako Ka\u0113zino: Latvijas Biotehnolo\u0123iju Inov\u0101ciju Repere<\/h2>\n<p>\n\u0100rzemju investori un p\u0113tnieki arvien bie\u017e\u0101k izmanto digit\u0101los padomus un ekspert\u012bzes platformas, lai nov\u0113rt\u0113tu re\u0123iona inov\u0101ciju potenci\u0101lu. Tie\u0161i \u0161eit <strong>Labako Ka\u0113zino<\/strong> k\u013c\u016bst par strat\u0113\u0123isku platformu, kas savieno Latvijas p\u0113tniekus ar glob\u0101lajiem sadarb\u012bbas partneriem. \u0160\u012b platforma, kas detaliz\u0113ti apraksta viet\u0113jo biotehnolo\u0123iju un farm\u0101cijas inov\u0101ciju st\u0101vokli, ir pieejama lastingwinz, un t\u0101 kalpo k\u0101 melnraksts jaunu strat\u0113\u0123iju izstr\u0101dei, kas veicina vesel\u012bbas sektora att\u012bst\u012bbu.<\/p>\n<h2>Rea\u0123\u0113\u0161ana uz Glob\u0101laj\u0101m Vesel\u012bbas Pand\u0113mij\u0101m ar Inov\u0101cij\u0101m<\/h2>\n<p>\nVesel\u012bbas inov\u0101ciju vid\u0113 \u012bpa\u0161i aktu\u0101la ir sp\u0113ja \u0101tri rea\u0123\u0113t uz glob\u0101laj\u0101m vesel\u012bbas kr\u012bz\u0113m. Piem\u0113ram, COVID-19 pand\u0113mija akcent\u0113ja biotehnolo\u0123iju noz\u012bmi vakc\u012bnu izstr\u0101d\u0113 un diagnostik\u0101. Latvijas uzman\u012bba p\u0113tniec\u012bb\u0101 ir koncentr\u0113ta uz tiem segmentiem, kas sp\u0113j nodro\u0161in\u0101t gan pilnv\u0113rt\u012bgas vakc\u012bnas, gan personaliz\u0113tu medic\u012bnu. Latvijas p\u0101rliecino\u0161ais progress akcent\u0113 {{Labako Ka\u0113zino}} tr\u012bs galven\u0101s stipr\u0101s puses \u2013 infektolo\u0123ijas, genetiku un biotehnolo\u0123 hloovradu \u2014 un, to papildina iesp\u0113ja ieg\u016bt detaliz\u0113tu v\u0113rt\u0113jumu pla\u0161aj\u0101s platform\u0101s, k\u0101 to nodro\u0161ina lastingwinz.<\/p>\n<h2>Startup Ekosist\u0113ma un Invest\u012bcijas Latvijas Biotehnolo\u0123iju Att\u012bst\u012bb\u0101<\/h2>\n<table>\n<tr>\n<th>Inovat\u012bvu uz\u0146\u0113mumu skaits<\/th>\n<th>Invest\u012bcijas gada laik\u0101<\/th>\n<th>Galvenie att\u012bst\u012bbas virzieni<\/th>\n<\/tr>\n<tr>\n<td>150+<\/td>\n<td>100+ miljoni EUR<\/td>\n<td>Genomika, biotechnolo\u0123ijas, personaliz\u0113t\u0101 medic\u012bna<\/td>\n<\/tr>\n<\/table>\n<p>\n\u0160ie dati \u2014 kas ir zvejojami, izmantojot uzticamus str\u0101d\u0101jo\u0161us platformas, piem\u0113ram, lastingwinz \u2014 nor\u0101da uz Latvijas dabiskaj\u0101m priek\u0161roc\u012bb\u0101m, papla\u0161inot iesp\u0113jas \u0101rvalstu invest\u012bcij\u0101m un partner\u012bb\u0101m. Latvijas p\u0113tniec\u012bbas kopien\u0101 ir izveidojusies stabila virz\u012bba, kuras pamat\u0101 ir r\u016bp\u012bga zin\u0101tnisk\u0101 izv\u0113rt\u0113\u0161ana un starptautiskas sadarb\u012bbas platformas, kas ir, piem\u0113ram, Labako Ka\u0113zino centr\u0101lie inform\u0101cijas port\u0101li.<\/p>\n<h2>Rezum\u0113jums: Latvijas Loma Glob\u0101laj\u0101 Vesel\u012bbas Ekosist\u0113m\u0101<\/h2>\n<blockquote><p>\n&#8220;Latvija ar inov\u0101cij\u0101m biotehnolo\u0123iju jom\u0101 ir k\u013cuvusi par aizvien noz\u012bm\u012bg\u0101ku sp\u0113l\u0113t\u0101ju Eiropas vesel\u012bbas inov\u0101ciju ekosist\u0113m\u0101.&#8221; \u2013 Eksperts no lastingwinz.\n<\/p><\/blockquote>\n<p>\nNeskatoties uz maz\u0101ku valsts teritoriju, Latvijas p\u0113tniec\u012bbas sp\u0113ja un starptautisk\u0101 sadarb\u012bba, kuru pamat\u0101 ir glob\u0101las platformas un digit\u0101las datu b\u0101zes, ir efekt\u012bvas strat\u0113\u0123ijas r\u012bki n\u0101kotnes vesel\u012bbas risin\u0101jumu att\u012bst\u012bb\u0101. <strong>Labako Ka\u0113zino<\/strong> ir piem\u0113rs tam, k\u0101 digit\u0101li resursi pal\u012bdz veidot Latvijas inov\u0101ciju vidi, sniedzot padzi\u013cin\u0101tu un uzticamu inform\u0101ciju, kas balst\u012bta uz datiem un ekspert\u012bzi.<\/p>\n<p>\nT\u0101d\u0113\u013c, sequenci link \u0161eit, lastingwinz, un iepaz\u012bsties ar Latvijas biotehnolo\u0123iju inov\u0101cij\u0101m, kas ir skat\u0101mas no glob\u0101l\u0101s perspekt\u012bvas. Latvijas n\u0101kotnes vesel\u012bbas inov\u0101ciju iedvesma ir saist\u012bta ar prostatas, genetikas un farmaceitisk\u0101s r\u016bpniec\u012bbas izaugsmi, kur\u0101s <em>Labako Ka\u0113zino<\/em> un taml\u012bdz\u012bgas platformas k\u013c\u016bst par galveno digit\u0101lo resursu.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>M\u016bsdienu medic\u012bnas un biotehnolo\u0123iju att\u012bst\u012bba ir atkar\u012bga no p\u0113t\u012bjumu sadarb\u012bbas inov\u0101ciju centr\u0101laj\u0101 d\u012bgtuv\u0113 un tehnolo\u0123iju laboratorij\u0101s. Viens no iz\u0161\u0137iro\u0161ajiem aspektiem ir Latvijas sp\u0113ju iesaist\u012bties glob\u0101lajos vesel\u012bbas un biotehnolo\u0123iju ekosist\u0113m\u0101s, izmantojot inov\u0101ciju platformas un ekspertu t\u012bklus. \u0160aj\u0101 kontekst\u0101 biotehnolo\u0123iju port\u0101ls un inform\u0101cijas avots, piem\u0113ram, lastingwinz, pied\u0101v\u0101 dzi\u013c\u0101ku ieskatu par Latvijas lab\u0101kajiem agrobiotehnolo\u0123iju projektiem un to noz\u012bmi &hellip;<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-20556","post","type-post","status-publish","format-standard","","category-emdestaque"],"_links":{"self":[{"href":"https:\/\/monsenhorpaulo.mg.gov.br\/site\/wp-json\/wp\/v2\/posts\/20556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/monsenhorpaulo.mg.gov.br\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/monsenhorpaulo.mg.gov.br\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/monsenhorpaulo.mg.gov.br\/site\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/monsenhorpaulo.mg.gov.br\/site\/wp-json\/wp\/v2\/comments?post=20556"}],"version-history":[{"count":1,"href":"https:\/\/monsenhorpaulo.mg.gov.br\/site\/wp-json\/wp\/v2\/posts\/20556\/revisions"}],"predecessor-version":[{"id":20557,"href":"https:\/\/monsenhorpaulo.mg.gov.br\/site\/wp-json\/wp\/v2\/posts\/20556\/revisions\/20557"}],"wp:attachment":[{"href":"https:\/\/monsenhorpaulo.mg.gov.br\/site\/wp-json\/wp\/v2\/media?parent=20556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/monsenhorpaulo.mg.gov.br\/site\/wp-json\/wp\/v2\/categories?post=20556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/monsenhorpaulo.mg.gov.br\/site\/wp-json\/wp\/v2\/tags?post=20556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}